Global Product Director of Oncology, QIAGEN Digital Insights
BIOGRAPHY
OCT 07, 2021 12:00 PM PDT
Panel Presentation: Oncology Variant Interpretation Just Got More Precise
Speakers
-
Sheryl Elkin, PhD
Chief Scientific Officer, QIAGEN Digital InsightsBIOGRAPHY
Abstract
Competing to offer a comprehensive genomic profiling service for solid or hematology oncology tumor samples is challenging, especially as panels increase in size and complexity. QIAGEN Clinical Insight (QCI) Interpret One is clinical decision support software integrated with professional variant interpretation services that enables rapid, evidence-based reporting of oncology NGS tests at scale.
Connected to the world’s most comprehensive, manually curated knowledge base that is updated weekly, QCI Interpret One dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines with full transparency. Users get access to over 200,000 pre-formulated, oncologist-reviewed variant interpretation summaries and can build customizable, oncologist-ready reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.
Learning Objectives:
1. Discuss how QCI Interpret One computes variant classifications.
2. Discuss how simple it is to submit variants for professional interpretation via the software.
3. Discuss how QCI Interpret One eliminates the need for variant curation.
4. Discuss how users can generate customizable, oncologist-ready reports according to AMP/ASCO/CAP guidelines for therapeutic, prognostic, and diagnostic actionability.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...